WO2006108714A3 - Tetrahydronaphtalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer - Google Patents

Tetrahydronaphtalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer Download PDF

Info

Publication number
WO2006108714A3
WO2006108714A3 PCT/EP2006/003783 EP2006003783W WO2006108714A3 WO 2006108714 A3 WO2006108714 A3 WO 2006108714A3 EP 2006003783 W EP2006003783 W EP 2006003783W WO 2006108714 A3 WO2006108714 A3 WO 2006108714A3
Authority
WO
WIPO (PCT)
Prior art keywords
antiphlogistics
production
tetrahydronaphthalene derivatives
derivatives method
tetrahydronaphthalene
Prior art date
Application number
PCT/EP2006/003783
Other languages
English (en)
French (fr)
Other versions
WO2006108714A2 (de
Inventor
Stefan Baeurle
Heike Schaecke
Markus Berger
Anne Mengel
Original Assignee
Schering Ag
Stefan Baeurle
Heike Schaecke
Markus Berger
Anne Mengel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag, Stefan Baeurle, Heike Schaecke, Markus Berger, Anne Mengel filed Critical Schering Ag
Publication of WO2006108714A2 publication Critical patent/WO2006108714A2/de
Publication of WO2006108714A3 publication Critical patent/WO2006108714A3/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines

Abstract

Die Erfindung betrifft mehrfach substituierteTetrahydronaphthalinderivate der Formel (I). Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer.
PCT/EP2006/003783 2005-04-14 2006-04-13 Tetrahydronaphtalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer WO2006108714A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005017286A DE102005017286B3 (de) 2005-04-14 2005-04-14 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
DE102005017286.5 2005-04-14

Publications (2)

Publication Number Publication Date
WO2006108714A2 WO2006108714A2 (de) 2006-10-19
WO2006108714A3 true WO2006108714A3 (de) 2007-01-04

Family

ID=36955993

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/003783 WO2006108714A2 (de) 2005-04-14 2006-04-13 Tetrahydronaphtalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer

Country Status (8)

Country Link
AR (1) AR056314A1 (de)
DE (1) DE102005017286B3 (de)
GT (1) GT200600153A (de)
PA (1) PA8668901A1 (de)
PE (1) PE20061313A1 (de)
TW (1) TW200716555A (de)
UY (1) UY29481A1 (de)
WO (1) WO2006108714A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2005034939A1 (de) 2003-10-08 2005-04-21 Schering Aktiengesellschaft Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EP1834948A1 (de) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
EP1917963A1 (de) * 2006-10-31 2008-05-07 Bayer Schering Pharma Aktiengesellschaft Cyclische Phenylsubstituierte Indazole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als entzündungshemmende Mittel

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03289659A (ja) * 1990-03-28 1991-12-19 Toshiba Corp 感光性組成物
WO1998050437A1 (en) * 1997-05-05 1998-11-12 First Chemical Corporation Biradical photoinitiators
WO2002016318A1 (en) * 2000-08-21 2002-02-28 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
WO2003095420A1 (en) * 2002-05-08 2003-11-20 Bayer Healthcare Ag Hydroxy tetrahydro-naphthalenylurea derivatives
WO2003097586A1 (en) * 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
WO2003101945A1 (en) * 2002-06-04 2003-12-11 Galderma Research & Development, S.N.C. Ligands that are inhibitors of the rar receptors
WO2005034939A1 (de) * 2003-10-08 2005-04-21 Schering Aktiengesellschaft Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038639A1 (de) * 2000-07-28 2002-02-21 Schering Ag Nichtsteroidale Entzündungshemmer

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03289659A (ja) * 1990-03-28 1991-12-19 Toshiba Corp 感光性組成物
WO1998050437A1 (en) * 1997-05-05 1998-11-12 First Chemical Corporation Biradical photoinitiators
WO2002016318A1 (en) * 2000-08-21 2002-02-28 Pacific Corporation Novel thiourea derivatives and the pharmaceutical compositions containing the same
WO2003095420A1 (en) * 2002-05-08 2003-11-20 Bayer Healthcare Ag Hydroxy tetrahydro-naphthalenylurea derivatives
WO2003097586A1 (en) * 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
WO2003101945A1 (en) * 2002-06-04 2003-12-11 Galderma Research & Development, S.N.C. Ligands that are inhibitors of the rar receptors
WO2005034939A1 (de) * 2003-10-08 2005-04-21 Schering Aktiengesellschaft Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer

Non-Patent Citations (19)

* Cited by examiner, † Cited by third party
Title
BANFI ET AL: "Enantio- and diastereoselective synthesis of the AB ring system of aklavinone by coupling a chemoenzymic procedure with organometal chemistry", TETRAHEDRON, vol. 52, no. 42, 1996, pages 13493 - 13512, XP002399949 *
BESTMANN ET AL: "Monoalkylboranes from alkylidenetriphenylphosphoranes and borane; combinations of ylide reactions and hydroboration", ANGEWANDTE CHEMIE, vol. 93, no. 12, 1981, pages 1098 - 1100, XP002399952 *
BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE , (6)(PT. 2), 2105-11 CODEN: BSCFAS; ISSN: 0037-8968, 1973 *
CALDIROLA, P. ET AL: "Conversion of isoxazolines to .beta.-hydroxy esters. Synthesis of 2-deoxy-D-ribose", TETRAHEDRON LETTERS, vol. 27, no. 38, 1986, pages 4647 - 4650, XP002399951 *
CROMWELL ET AL: "Epoxy ketones. V. Stereochemistry of 2-benzal-4,4-dimethyl-1-tetralone oxide. Diol synthesis", JOURNAL OF ORGANIC CHEMISTRY, vol. 26, 1961, pages 997 - 1003, XP002399946 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1957, GAIND, V. S. ET AL: "Polynuclear aromatic hydrocarbons. III. A new route to chrysene derivatives", XP002399963, retrieved from STN Database accession no. 1957:46977 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1971, TER-SARKISYAN, G. S. ET AL: "Organoboron compounds. Reactions of allyl compounds of boron with o- and p-quinones", XP002400163, retrieved from STN Database accession no. 1971:435516 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1974, PERROS, P. ET AL: "Mass spectrometry. IX. Electron-impact induced fragmentations of .alpha.-glycols in the tetralin series", XP002399961, retrieved from STN Database accession no. 1974:47027 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 1985, WANG, ZHEQIN ET AL: "Synthesis of (.+-.)-5,8-dimethoxy-2-ethyl-1,2,3,4-tetrahydro-2- naphthalenol - a precursor for the AB ring of anthracyclinone", XP002399960, retrieved from STN Database accession no. 1985:24346 *
DAVIS ET AL: "Asymmetric synthesis of the AB-ring of aklavinone", TERTRAHEDRON LETTERS, vol. 32, no. 52, 1991, pages 7671 - 7674, XP002399947 *
DAVIS ET AL: "Chemistry of oxaziridines. 16. A short, highly enantioselective synthesis of the AB-ring segments of .gamma.-rhodomycionone and .alpha.-citromycinone using (+)-[(8,8-dimethoxycamphoryl)sulfonyl]oxaziridine", JOURNAL OF ORGANIC CHEMISTRY, vol. 56, no. 3, 1991, pages 1143 - 1145, XP002399954 *
DEHMLOW ET AL: "Monodeazacinchona alkaloid derivatives: synthesis and preliminary applications as phase-transfer catalysts", EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, vol. 13, 2002, pages 2087 - 2093, XP002399953 *
J. INDIAN CHEM. SOC. , 33, 697-702, 1956 *
MASUI ET AL: "New method and reagents in organic synthesis. 75. Asymmetric synthesis of .alpha.-hydroxy ketones using chiral phase transfer catalysts", TETRAHEDRON LETTERS, vol. 29, no. 23, 1988, pages 2835 - 2838, XP002399955 *
MEYERS, A. I. ET AL: "Asymmetric additions to chiral naphthalenes. 4. Asymmetric synthesis of the AB-ring of aklavinone", JOURNAL OF ORGANIC CHEMISTRY, vol. 52, no. 20, 1987, pages 4592 - 4597, XP002399950 *
MORIKAWA ET AL: "Catalytic asymmetric dihydroxylation of tetrasubstituted olefins", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 115, no. 18, 1993, pages 8463 - 8464, XP002399945 *
NAKATA ET AL: "Asymmetric epoxidation with a photoactivated [Ru(salen)] complex", CHEMISTRY-A EUROPEAN JOURNAL, vol. 7, no. 17, 2001, pages 3779 - 3782, XP002399948 *
YIYAO GONGYE , (9), 42-4 CODEN: YIGODN; ISSN: 0255-7223, 1984 *
ZHURNAL OBSHCHEI KHIMII , 41(1), 152-8 CODEN: ZOKHA4; ISSN: 0044-460X, 1971 *

Also Published As

Publication number Publication date
WO2006108714A2 (de) 2006-10-19
DE102005017286B3 (de) 2006-12-28
TW200716555A (en) 2007-05-01
GT200600153A (es) 2007-03-19
UY29481A1 (es) 2006-10-31
PA8668901A1 (es) 2007-01-17
AR056314A1 (es) 2007-10-03
PE20061313A1 (es) 2006-12-20

Similar Documents

Publication Publication Date Title
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
IL179758A (en) Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof and use of the same as medicaments
IL174405A0 (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
WO2007093627A3 (de) Biozide zusammensetzung
ZA200801850B (en) Synthesized hybrid rock composition, method, and article formed by the method
EP1908749A4 (de) Verfahren zur herstellung von isocyanat, danach hergestelltes isocyanat und verwendung von isocyanat
WO2006018279A3 (de) Arylsubstituierte polycyclische amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
PL1954745T3 (pl) Preparat środka zwiększającego przyczepność, sposób jego wytwarzania oraz jego zastosowanie
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
WO2005121078A3 (de) Substituierte cyclopenten-verbindungen
ZA200802313B (en) Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
WO2007075870A3 (en) Processes for taxane derivatives and intermediates useful therein
WO2008058936A3 (de) Calciumformiat-düngemittel
WO2007012626A3 (de) Neues verfahren zur herstellung von tiotropiumsalzen
WO2006108714A3 (de) Tetrahydronaphtalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
WO2006117763A3 (en) A process for the preparation of doripenem
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
WO2006122777A3 (de) Verwendung von 2,5-disubstituierten thiazol-4-on-derivaten in arzneimitteln
EP1939184A4 (de) 1,3-diiodhydantoinverbindung und verfahren zu deren herstellung
WO2007009887A3 (de) Bariumsulfat enthaltende zubereitung
WO2006076350A3 (en) Processes for the preparation of aminoethoxybenzyl alcohols

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06753407

Country of ref document: EP

Kind code of ref document: A2